"Peptides for healing" is a search that returns a great deal of confident writing and very little mechanism. This covers the four compounds that actually recur in tissue-repair literature, what each is studied for, how they differ, and — since the differences are mechanistic rather than a ranking — why the question "which is best" does not have an answer.
Proxiva Formulation DeskBlends, fill weights and multi-component products
Key takeaways
- What does healing actually mean here? Until that is narrowed, no compound can be chosen.
- Is the interest structural, inflammatory, or metabolic? Those are three different literatures.
- Which compound has the deepest evidence? GHK-Cu, by a clear margin among the peptides here.
- Does a blend save money? Only if every component in it was wanted anyway.
- What has never been studied? The combinations, as combinations.
Why "which is best" is the wrong question
Almost every article on this topic ranks these compounds against one another. That framing does not survive contact with what they actually do.
Tissue repair is not one process. It involves new blood vessel formation, cell migration into the damaged area, remodelling of the extracellular matrix, and modulation of the inflammatory response — distinct processes running on different timescales through different machinery.
The four compounds below each appear in research on a different one of those. Asking which is best is like asking whether a hammer outperforms a wrench. The useful question is which process a given protocol is examining.
That is also why they are so often stocked together, and why combination products exist rather than the market consolidating around one winner.
The four, by mechanism
BPC-157 — angiogenic signalling
A 15-amino-acid synthetic peptide derived from a protein found in gastric juice. The research concentrates on angiogenesis — formation of new blood vessels — and on interactions with growth-factor signalling pathways. A substantial portion of the published work uses gastrointestinal models, consistent with its origin.
It is also unusually stable in aqueous solution for a peptide of its size, which is itself a subject of study and has practical handling consequences. Listed as BPC-157.
TB-500 — actin dynamics and cell migration
A synthetic fragment of Thymosin Beta-4, a 43-residue protein present in most mammalian cell types. Its defining biochemical property is binding monomeric G-actin, which regulates how readily actin polymerises into filaments. Since actin polymerisation underlies cell motility, this places it in cell-migration research.
Note that what is sold as TB-500 is usually the fragment rather than the full-length protein — a distinction covered in our TB-500 versus BPC-157 comparison. Listed as TB-500.
GHK-Cu — matrix remodelling
A tripeptide complexed with a copper ion. The literature here is comparatively deep and spans several decades, much of it concerning extracellular matrix remodelling and gene-expression effects in cell culture.
The copper is a structural component rather than an additive, which creates a verification problem specific to this compound: HPLC does not detect the metal at all. Covered in the GHK-Cu sourcing guide. Listed as GHK-Cu.
KPV — inflammatory signalling
A tripeptide corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone. It appears predominantly in research on inflammatory signalling, which is a different axis from the other three. Listed as KPV.
Side by side
| Length | Studied mechanism | Notable property | |
|---|---|---|---|
| BPC-157 | 15 residues | Angiogenic signalling | Unusually stable in solution |
| TB-500 | fragment of 43 | G-actin sequestration | Fragment vs full protein confusion is common |
| GHK-Cu | 3 residues + Cu | Matrix remodelling | Copper content needs separate testing |
| KPV | 3 residues | Inflammatory signalling | Fragment of alpha-MSH |
The lengths are worth noting for cost. Short peptides are cheaper to synthesise because yield compounds across coupling steps — which is why GHK-Cu and KPV price differently per milligram from the longer compounds.
Why blends exist here specifically
This is the area of a research catalogue where combination products are most common, and the reason is the non-overlap described above.
BPC-157 with TB-500 pairs the angiogenic and cytoskeletal mechanisms. GLOW combines GHK-Cu, TB-500 and BPC-157 — three of the four. KLOW is that same base plus KPV, making it all four in one vial.
The arithmetic is worth running before assuming a blend is the cheaper route, and in this case it favours them: bought as separate vials the GLOW components come to roughly $225 against the blend's $174, and KLOW's to roughly $275 against $190. The full breakdown is in our GLOW versus KLOW comparison.
What a blend costs you is the ratio, which is fixed at manufacture, and the ability to isolate a problem — if one component is substandard the whole vial is compromised. For work where the proportions are a variable, separate vials remain the right call.
Both blends are also available as the GLOW pen and the KLOW pen, and the individual compounds in pen format as BPC-157 and TB-500.
Two more that appear in the same searches
Beyond the core four, two compounds show up often enough in these searches to be worth placing accurately — mostly because they are frequently misfiled here.
AOD-9604 is a fragment of human growth hormone, specifically the C-terminal region. It appears in tissue-related searches by association with growth hormone rather than because the repair literature concerns it directly. Its studied mechanism is metabolic, not reparative, so its presence in a healing-focused protocol needs a reason beyond category adjacency.
SS-31 is a mitochondria-targeting tetrapeptide, studied for its interaction with cardiolipin in the inner mitochondrial membrane. That is a bioenergetic mechanism. It gets grouped with repair compounds because damaged tissue is metabolically stressed, but the connection is inferential rather than direct.
Both are legitimate research compounds and both are mis-described constantly. The general pattern worth recognising: compounds get filed under "healing" by topical association, and the filing then gets treated as a claim about mechanism. Checking what a compound actually binds is the fastest way to sort a real candidate from a category error.
Researchers assembling broader panels in this area commonly also hold Ipamorelin, CJC-1295 no-DAC, MOTS-c, Epithalon, NAD+, Glutathione, DSIP and L-Carnitine, with bacteriostatic water for reconstitution across all of them.
What the evidence actually supports
A caveat that applies to everything above, and that most writing on this topic omits.
The overwhelming majority of published work on these four compounds is in vitro or animal-model research. That work is real and the mechanisms described are documented. What it does not establish is what happens in humans.
The gap between the two is where most online claims live. A compound that promotes angiogenesis in a cell-culture assay has demonstrated something specific and limited. Descriptions that translate that into outcomes are making an inference several steps beyond the data, and generally without saying so.
GHK-Cu is the partial exception in that its literature is deeper and older than the others', which makes claims about it easier to trace to primary sources. For the rest, the honest position is that mechanism is documented and outcome is not.
This matters practically when comparing suppliers. A vendor describing what these compounds do to people is making claims it cannot substantiate — which tells you something about the rest of its documentation. Covered further in choosing a research peptide supplier.
Sourcing and handling
Verification is the same across all four, with one addition for GHK-Cu.
- HPLC purity with the chromatogram image, not a bare percentage
- Mass-spectrometry identity — for TB-500 this is what separates the fragment from the full protein
- Copper content for GHK-Cu, reported separately; HPLC cannot see the metal
- Batch number matching the vial label exactly
- Named testing laboratory, independent of synthesis
- Residual solvent panel covering TFA, acetonitrile and DMF
Handling is ordinary peptide discipline throughout: lyophilised powder cold, dry and dark; reconstitution with bacteriostatic water for multi-draw vials; diluent down the wall rather than onto the cake; swirl rather than shake; refrigerate and label afterwards; never re-freeze. GHK-Cu warrants stricter light protection than the others because copper complexes are more photosensitive.
Full procedures are in reconstituting research peptides and storage and stability.
Frequently asked questions
Which peptide is best for healing?
What kind of healing? Structural repair, inflammatory modulation and metabolic recovery are separate processes with separate literatures. Which one describes your question?
Is GHK-Cu the strongest option?
It has the largest and oldest literature of the peptides here — but does that make it right for you? Only if your interest is matrix and structural processes. If it is not, depth of evidence about the wrong thing helps nobody.
Should I buy a blend or single components?
Do you want every component in the blend? If yes, a blend is cheaper. If no, why pay for the ones you will not use? And do you need to vary one against another? A blend forecloses that permanently.
Are combinations better evidenced than single compounds?
No — and is that surprising? Blends are assembled rather than discovered. Nothing has studied these combinations as combinations, so what would the evidence even consist of?
How do I know the material is what it claims?
Have you asked for a batch-matched certificate? Did you read identity before purity? Did you open the chromatogram, or only the summary page? Most verification fails at the third question.
What if my question spans several processes?
Then is it one question, or several? Work spanning multiple processes needs components that can vary independently, which means individual vials rather than a fixed blend.
Related research compounds
Further reading
- TB-500 vs BPC-157: A Side-by-Side Research Comparison
- TB-500, Actin Polymerisation and Cell Migration: The Mechanism
- Choosing a Research Peptide Supplier in 2026: A Verification Checklist
- Where to Buy Thymosin Beta-4 (TB-500): Purity, COA and Sourcing
- How to Read a Peptide Certificate of Analysis: HPLC, Mass Spec and Red Flags
Research use only. All products referenced on this page are sold strictly for laboratory and research purposes. They are not drugs, foods, cosmetics, or medical devices, and they are not intended to diagnose, treat, cure, or prevent any disease. They are not for human or veterinary consumption. Handling should be performed only by qualified individuals in an appropriate laboratory setting.